PC-SPES studies
This article was originally published in The Tan Sheet
Executive Summary
NCCAM-funded PC-SPEStrials, on hold since BotanicLab recalled the supplement in February, will remain in limbo until at least July, NIH center says. NCCAM decision-makers currently are meeting with PC-SPES study "stakeholders," patients, researchers to determine course of action. Trial's investigators hope additional sources of PC-SPES will become available. Of the four trials, three were in vitro studies; research involving humans had not yet begun (1"The Tan Sheet" June 3, 2002, p. 5)...